# Anakinra in Dengue With Hyperinflammation ( AnaDen )

> **NCT05611710** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Oxford University Clinical Research Unit, Vietnam** · enrollment: 160 (estimated)

## Conditions studied

- Dengue
- Dengue With Warning Signs
- Severe Dengue
- Anakinra
- Immuno-modulation
- Anti-inflammatory Agents
- Macrophage Activation Syndrome
- Hyperinflammatory Syndrome
- Cytokine Storm

## Interventions

- **DRUG:** Placebo
- **DRUG:** Anakinra

## Key facts

- **NCT ID:** NCT05611710
- **Lead sponsor:** Oxford University Clinical Research Unit, Vietnam
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-01-02
- **Primary completion:** 2025-10-20
- **Final completion:** 2027-12-31
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2026-01-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05611710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05611710, "Anakinra in Dengue With Hyperinflammation ( AnaDen )". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT05611710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*